MRK Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Merck & Co Inc. Stock Analysis MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Kenilworth, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Human health vaccine products consist of preventive pediatric, adolescent and adult vaccines. The Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. The company is also engaged in developed a novel class of small molecules that target cancer cells lacking expression of a key DNA repair protein called O6-methylguanine methyl transferase.
Read More MRK Chart
Merck & Co Inc vs S&P 500 Comparative Returns
Analysis of MRK stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- Merck & Co Inc (MRK) -21.94%
- S&P 500 -4.27%
Merck & Co Inc Underperformed S&P 500 by 17.67%
1Y Performance
- Merck & Co Inc (MRK) -40.06%
- S&P 500 8.86%
Merck & Co Inc Underperformed S&P 500 by 48.92%
3Y Performance
- Merck & Co Inc (MRK) -11.4%
- S&P 500 37.21%
Merck & Co Inc Underperformed S&P 500 by 48.61%
5Y Performance
- Merck & Co Inc (MRK) 6.59%
- S&P 500 92.3%
Merck & Co Inc Underperformed S&P 500 by 85.71%
Key Statistics
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$78.50Volume
11.67MP/E Ratio (TTM)
11.4552 Week Range
Market Cap
233.18BAvg. Volume
14.81MDividend Yield
4.00%Financial Metrics & Statements
- Per Share Data
- Ratios
- Statements
Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Revenue per Share (TTM) | 16.41 | 19.27 | 23.36 | 23.75 | - |
EBIT per Share (TTM) | 4.32 | 6.16 | 8 | 1.61 | - |
Earnings per Share (EPS) (TTM) | 2.79 | 5.16 | 5.73 | 0.14 | - |
Dividend per Share (TTM) | 2.46 | 2.62 | 2.76 | 2.94 | - |
EPS Forward | 2.78 | 5.14 | 5.71 | 0.14 | 6.74 |
Super Investors
View All ➜Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Kahn Brothers
% Portfolio:
11.00 Recent Activity:-12.33%
Barrow, Hanley, Mewhinney & Strauss
% Portfolio:
2.13 Recent Activity:11.13%
Charles Brandes
% Portfolio:
1.70 Recent Activity:11.21%
Prem Watsa
% Portfolio:
1.11 Recent Activity:-

Community-Curated Collections ( With MRK )
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
Dow Jones Industrial Average Index
By Dilnoza Mirsaidova
208 Followers
Biotech & Drugs
By Bunyod Rayim
44 Followers
US Mega Cap Stocks
By Dilnoza Mirsaidova
39 Followers
Top 20 halal companies from S&P 500
By Investment Alchemist
30 Followers
nasim_stock
By Md Nasimul Haq
22 Followers
My Watchlist
By Mustafa SARICA
15 Followers
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.